By Counterforce Health Team in Krystexxa (pegloticase) —

How to Get Krystexxa (Pegloticase) Covered by Blue Cross Blue Shield in Georgia: Prior Authorization, Appeals, and State Protections Guide

Answer Box: Getting Krystexxa Covered by Blue Cross Blue Shield in Georgia

Fastest path to approval: Submit prior authorization through BCBS provider portal with complete documentation of failed xanthine oxidase inhibitor trials (allopurinol/febuxostat), G6PD test results, and rheumatology evaluation. Georgia's step therapy exception law (§33-24-59.25) requires approval within 2 business days if contraindications or prior failures are documented. If denied, file internal appeal within 180 days, then external review through Georgia Insurance Commissioner within 60 days of final denial.

First step today: Contact your rheumatologist to gather documentation of prior gout therapy failures and request G6PD testing if not already completed.

Table of Contents

  1. Why Georgia State Rules Matter for Krystexxa Coverage
  2. Prior Authorization Turnaround Standards
  3. Georgia Step Therapy Exception Protections
  4. Continuity of Care During Transitions
  5. External Review and Regulatory Complaints
  6. Practical Scripts and Documentation
  7. ERISA Plan Limitations
  8. Quick Reference Contacts
  9. FAQ

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all BCBS plans Provider portal, policy CC-0057 Anthem Clinical Criteria
Step Therapy Must fail allopurinol/febuxostat first Georgia Code §33-24-59.25 Georgia Step Therapy Law
G6PD Testing Required before first dose FDA labeling requirements Krystexxa HCP Site
Rheumatology Evaluation Strongly preferred by most BCBS policies Medical policy documents BCBS Medical Policies
Appeal Deadline 180 days from denial notice Plan documents Coverage Rights Georgia
External Review 60 days from final internal denial Georgia OCI Rule 120-2-111 Georgia External Review Rules

Why Georgia State Rules Matter for Krystexxa Coverage

Georgia's insurance laws create specific protections that can override Blue Cross Blue Shield's standard denial patterns, particularly for specialty drugs like Krystexxa (pegloticase). Understanding how state and federal rules interact with your specific BCBS plan type is crucial for success.

Plan Type Differences

Fully Insured Plans (most individual and small group plans):

  • Subject to Georgia step therapy exception law
  • Must follow Georgia external review process
  • Protected by surprise billing and network adequacy rules

Self-Funded ERISA Plans (many large employers):

  • Follow federal rules only
  • May voluntarily adopt Georgia standards
  • Limited to federal appeal processes
Tip: Ask your HR department or call the member services number on your card to determine if your plan is fully insured or self-funded.

Prior Authorization Turnaround Standards

Georgia law and BCBS policies establish specific timelines that can work in your favor when properly invoked.

Standard Review Timelines

Review Type Georgia Requirement BCBS Standard When to Use
Urgent/Expedited 24 hours 72 hours Severe uncontrolled gout, frequent hospitalizations
Standard Pre-Service 15 days 30 days Initial authorization requests
Step Therapy Exception 2 business days Varies When citing Georgia §33-24-59.25

Renewal Requirements

Most BCBS Krystexxa policies require renewal every 6-12 months with documentation of:

  • Serum uric acid levels <6 mg/dL prior to infusions
  • Reduction in gout flares or tophi shrinkage
  • Absence of serious adverse reactions
  • Continued rheumatology oversight

Georgia Step Therapy Exception Protections

Georgia Code §33-24-59.25 provides powerful tools to bypass BCBS step therapy requirements when medically appropriate.

Mandatory Override Criteria

BCBS must approve a step therapy exception within 2 business days if your documentation shows:

  1. Contraindication/Risk: Required step drug will cause adverse reaction or harm
  2. Expected Ineffectiveness: Step drug unlikely to work based on patient characteristics
  3. Prior Failure: Patient previously tried and failed the required drug
  4. Current Stability: Patient stable on requested drug; switching not in best interest
  5. Clinical Inappropriateness: Step drug not suitable for the specific indication

Required Documentation

For chronic gout step therapy exceptions, include:

Treatment History:

  • Complete list of prior urate-lowering therapies
  • Specific doses, durations (minimum 3 months when tolerated)
  • Objective outcomes (serum urate levels, flare frequency)
  • Documented side effects or contraindications

Clinical Severity:

  • Number of gout flares per year
  • Presence and description of tophi
  • Joint damage or functional impairment
  • Impact on work or daily activities

Supporting Evidence:

  • G6PD test results (normal)
  • Recent serum uric acid levels
  • Rheumatology consultation notes
  • Relevant imaging or photographs
From our advocates: We've seen Georgia patients successfully overturn BCBS denials by explicitly citing the state step therapy law in their appeal letters and providing detailed documentation of allopurinol hypersensitivity reactions. The key is matching your clinical situation to the specific legal criteria and requesting the mandated 2-business-day timeline.

Continuity of Care During Transitions

Georgia's network adequacy rules under the CATCH Act and surprise billing protections help maintain access during plan changes or provider network disruptions.

Transition Scenarios

Plan Changes (Open Enrollment/Job Changes):

  • Request transition fills while new PA processes
  • Document current clinical stability on Krystexxa
  • Emphasize risks of treatment interruption

Provider Network Changes:

  • Invoke CATCH Act network adequacy requirements
  • File complaint with Georgia OCI if no reasonable alternatives
  • Request single-case agreements for continuity

Formulary Changes Mid-Year:

  • Plans must provide advance notice
  • Transition periods often available
  • Appeal based on clinical stability

Georgia Surprise Billing Protections

If your infusion center becomes out-of-network but you have no reasonable in-network alternative:

  • You may be protected from balance billing
  • File complaint with Georgia OCI
  • Document lack of network alternatives

External Review and Regulatory Complaints

Georgia's external review process provides binding decisions that BCBS must follow.

When You're Eligible

External review is available for fully insured Georgia plans when:

  • Internal appeals have been exhausted
  • Denial is based on medical necessity
  • Request filed within 60 days of final denial
  • All required documentation submitted

How to File

  1. Complete Georgia OCI external review application
  2. Include all supporting documents:
    • Original denial letters
    • Internal appeal decisions
    • Complete medical records
    • Physician statements
  3. Submit to assigned Independent Review Organization
  4. Decision rendered within 60 days

What to Include in Your Request

Clinical Documentation:

  • Comprehensive gout treatment history
  • Evidence of refractory disease despite standard therapy
  • Rheumatology evaluation supporting Krystexxa necessity
  • G6PD test results and safety monitoring plan

Legal Arguments:

  • Reference to Georgia step therapy exception law
  • Network adequacy concerns under CATCH Act
  • Surprise billing protections if applicable
  • Federal guideline support for pegloticase in refractory gout

Contact Information:

  • Georgia Office of Insurance: (404) 656-2070 or (800) 656-2298
  • Consumer complaint portal: oci.georgia.gov

Practical Scripts and Documentation

Patient Phone Script for BCBS

"I'm calling about prior authorization for Krystexxa, HCPCS code J2507. I have chronic refractory gout and have failed standard therapy with allopurinol and febuxostat. Under Georgia law section 33-24-59.25, I'm requesting a step therapy exception based on prior treatment failures. I need to know your specific PA form and submission process, and I'm requesting expedited review due to severe uncontrolled gout affecting my daily function."

Medical Necessity Letter Checklist

Your rheumatologist should address:

✓ Diagnosis: Chronic gout refractory to conventional therapy
✓ Disease severity: Flare frequency, tophi, joint damage
✓ Prior therapies: Specific agents, doses, durations, outcomes
✓ Contraindications: Why alternatives are inappropriate
✓ Krystexxa rationale: Expected benefits, monitoring plan
✓ Safety considerations: G6PD status, infusion setting
✓ Guideline support: Reference to ACR or other evidence

Appeal Letter Template Paragraph

"This request meets Georgia step therapy exception criteria under O.C.G.A. §33-24-59.25 based on documented prior failure of required step therapies. The patient has trialed allopurinol 300mg daily for 4 months with persistent serum urate >8 mg/dL and continued flares, and febuxostat 80mg daily for 3 months with similar lack of efficacy. These failures are objectively documented in the attached clinical records. Georgia law requires approval of this exception within 2 business days of complete submission."

ERISA Plan Limitations

If you have insurance through a large employer, your plan may be self-funded and governed by federal ERISA law rather than Georgia insurance regulations.

Key Differences

ERISA Plans:

  • Not subject to Georgia step therapy exception law
  • Follow federal appeal timelines (may be longer)
  • No access to Georgia external review process
  • Must exhaust plan appeals before federal court

What Still Applies:

  • Federal surprise billing protections
  • ACA internal and external review requirements
  • Basic medical necessity standards

How to Identify Your Plan Type

  • Check your insurance card for "administered by" language
  • Ask HR if the plan is "fully insured" or "self-funded"
  • Look for ERISA disclosures in plan documents

Quick Reference Contacts

Georgia Resources

  • Georgia Office of Insurance Consumer Services: (800) 656-2298
  • External Review Applications: oci.georgia.gov
  • Georgians for a Healthy Future: Consumer assistance nonprofit

BCBS Resources

  • Provider Portal: Anthem/BCBS Georgia provider login
  • Member Services: Number on back of insurance card
  • Clinical Criteria: Policy CC-0057 for Krystexxa

Manufacturer Support

  • Krystexxa Patient Support: krystexxahcp.com
  • Amgen Patient Assistance: Financial support programs

FAQ

How long does BCBS prior authorization take in Georgia? Standard PA decisions are due within 15-30 days, but Georgia's step therapy exception law requires decisions within 2 business days when properly invoked with documented prior failures or contraindications.

What if Krystexxa is non-formulary on my BCBS plan? You can request a formulary exception by documenting medical necessity and failure of covered alternatives. The process is similar to prior authorization but may require additional justification.

Can I request an expedited appeal for Krystexxa? Yes, if delaying treatment could seriously jeopardize your health. Severe uncontrolled gout with frequent flares or progressive joint damage typically qualifies for urgent review within 24-72 hours.

Does step therapy apply if I failed treatments in another state? Yes, documented treatment failures from other states count toward Georgia step therapy exception criteria. Include complete medical records from your previous providers.

What happens if BCBS misses the appeal deadline? For fully insured plans, you can file a complaint with Georgia OCI for procedural violations. The insurer may be required to approve the request or face regulatory action.

Do I need a rheumatologist to prescribe Krystexxa? While not always legally required, most BCBS policies strongly prefer or require rheumatology involvement due to the drug's complexity and safety monitoring requirements.

Counterforce Health helps patients navigate complex prior authorization and appeal processes by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to identify the specific criteria needed for approval, then drafts point-by-point rebuttals using the right clinical evidence and regulatory citations. Visit counterforcehealth.org to learn how we can help streamline your appeal process.

When dealing with specialty drug denials, having the right documentation and legal framework can make the difference between approval and prolonged treatment delays. Georgia's consumer protection laws provide several pathways to challenge inappropriate denials, but success depends on understanding which rules apply to your specific situation and how to properly invoke them.

For complex cases involving multiple denials or procedural violations, Counterforce Health can help analyze your specific situation and develop a comprehensive appeal strategy that addresses both clinical and regulatory requirements.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on your specific plan terms and clinical circumstances. Always consult with your healthcare provider and review your plan documents for the most current requirements. For personalized assistance with prior authorization and appeals, consider consulting with qualified healthcare advocates or legal professionals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.